Assessment of sociodemographic factors in timely endometrial cancer diagnosis following an abnormal transvaginal ultrasound performed for postmenopausal bleeding.
Sage Atkins,Angela Nolin,Shakthi Unnithan,Evan R. Myers,Haley Moss,Alaattin Erkanli,Laura J. Havrilesky
DOI: https://doi.org/10.1200/jco.2024.42.16_suppl.e17595
IF: 45.3
2024-06-01
Journal of Clinical Oncology
Abstract:e17595 Background: Postmenopausal bleeding (PMB) is the most common initial presentation of endometrial cancer. The American College of Obstetrics and Gynecology recommends evaluation of PMB with transvaginal ultrasound (TVUS) to determine the endometrial stripe (ES) thickness, followed by tissue sampling if ES >4 mm. We assessed if differences in race, ethnicity, language, or insurance status were associated with delayed endometrial sampling following an abnormal ES on TVUS, and if the timing of endometrial sampling after TVUS was associated with differences in rates of endometrial cancer diagnosis and staging. Methods: We conducted a retrospective study of consecutive patients with an intact uterus and PMB who presented to a single academic institution and underwent TVUS between January 2013-December 2022. TVUS was characterized as normal (ES ≤4 mm), abnormal (ES >4 mm), or inadequate (ES not fully visualized). Prompt sampling was defined as sampling with endometrial pathology within 3 months of abnormal TVUS. Logistic regression analyses were performed to characterize associations between race, ethnicity, preferred language, insurance status and prompt endometrial sampling. We assessed rates of endometrial cancer diagnosis and stage at diagnosis, comparing sampling at ≤3 versus 3-12 months after TVUS. Results: Among 3,369 patients meeting inclusion criteria, 1,671 (50%) had abnormal ES. Out of the total cohort, patients with an abnormal ES comprised 576/1336 (43%) of Black or African American and 946/1889 (50%) of White patients. 307/1671 (18%) of patients with abnormal ES did not receive prompt sampling. Neither race (Black OR 1.03, 95% CI 0.79-1.35 vs White), ethnicity, (Hispanic OR 1.1, 95% CI 0.54-2.27 vs. non-Hispanic), non-English primary/preferred language (OR 0.9, 95% CI 0.47-1.71 vs English), nor Medicare insurance status (OR 0.96, 95% CI 0.65-1.42 vs private insurance, age-adjusted) were associated with prompt endometrial sampling after abnormal ES. Endometrial cancer was diagnosed in 147/1227 (12%) of cases who underwent sampling for abnormal ES (143/1165 (12%) with prompt sampling and 4/62 (6%) with delayed sampling). The stage distribution of endometrial cancers diagnosed after prompt sampling was 107/133 (80%) Stage I and 26/133 (20%) stage II-IV, compared to 2/4 (50%) stage IA and 2/4 (50%) stage II-IV after delayed sampling. Conclusions: One in five patients with PMB and an abnormal appearing endometrium on ultrasound did not receive appropriate sampling within 3 months. Race, ethnicity, language, and insurance status were not associated with timely receipt of endometrial sampling following an abnormal ultrasound. With prompt endometrial sampling for abnormal TVUS, 80% of endometrial cancers are diagnosed at the earliest stage.
oncology